Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

2.

Ropinirole treatment for restless legs syndrome.

Chitnis S.

Expert Opin Drug Metab Toxicol. 2008 May;4(5):655-64. doi: 10.1517/17425255.4.5.655 . Review.

PMID:
18484922
3.

Ropinirole treatment for restless legs syndrome.

Bogan RK.

Expert Opin Pharmacother. 2008 Mar;9(4):611-23. doi: 10.1517/14656566.9.4.611. Review.

PMID:
18312162
4.

Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis.

Zintzaras E, Kitsios GD, Papathanasiou AA, Konitsiotis S, Miligkos M, Rodopoulou P, Hadjigeorgiou GM.

Clin Ther. 2010 Feb;32(2):221-37. doi: 10.1016/j.clinthera.2010.01.028. Review.

PMID:
20206780
5.

Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.

Fulda S, Wetter TC.

Brain. 2008 Apr;131(Pt 4):902-17. Epub 2007 Oct 11. Review.

PMID:
17932100
6.

Ropinirole: for the treatment of restless legs syndrome.

Cheer SM, Bang LM, Keating GM.

CNS Drugs. 2004;18(11):747-54; discussion 755-6. Review.

PMID:
15330688
7.

Ropinirole in the treatment of restless legs syndrome.

Kakar RS, Kushida CA.

Expert Rev Neurother. 2005 Jan;5(1):35-42. Review.

PMID:
15853472
8.

The weight of evidence for ropinirole in restless legs syndrome.

Trenkwalder C.

Eur J Neurol. 2006 Oct;13 Suppl 3:21-30. Review.

PMID:
16930379
9.

Dopamine agonists for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD006009. doi: 10.1002/14651858.CD006009.pub2. Review.

PMID:
21412893
10.

Pramipexole: in restless legs syndrome.

McCormack PL, Siddiqui MA.

CNS Drugs. 2007;21(5):429-37; discussion 438-40. Review.

PMID:
17447832
11.

Treatment options for restless legs syndrome.

Ferini-Strambi L.

Expert Opin Pharmacother. 2009 Mar;10(4):545-54. doi: 10.1517/14656560902793605 . Review.

PMID:
19284359
12.

Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis.

Wilt TJ, MacDonald R, Ouellette J, Khawaja IS, Rutks I, Butler M, Fink HA.

JAMA Intern Med. 2013 Apr 8;173(7):496-505. doi: 10.1001/jamainternmed.2013.3733. Review.

PMID:
23460396
13.

Sequential compression devices for treatment of restless legs syndrome.

Eliasson AH, Lettieri CJ.

Medicine (Baltimore). 2007 Nov;86(6):317-23. Review.

14.

Role of dopamine receptor agonists in the treatment of restless legs syndrome.

Happe S, Trenkwalder C.

CNS Drugs. 2004;18(1):27-36. Review.

PMID:
14731057
15.

New paradigms in the treatment of restless legs syndrome.

Thorpy MJ.

Neurology. 2005 Jun 28;64(12 Suppl 3):S28-33. Review.

PMID:
15994221
16.

Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.

Varga LI, Ako-Agugua N, Colasante J, Hertweck L, Houser T, Smith J, Watty AA, Nagar S, Raffa RB.

J Clin Pharm Ther. 2009 Oct;34(5):493-505. doi: 10.1111/j.1365-2710.2009.01025.x. Review.

PMID:
19744006
17.

Restless legs syndrome: treatment with dopaminergic agents.

Comella CL.

Neurology. 2002 Feb 26;58(4 Suppl 1):S87-92. Review.

PMID:
11909990
18.

Restless legs syndrome in the older adult: diagnosis and management.

Milligan SA, Chesson AL.

Drugs Aging. 2002;19(10):741-51. Review.

PMID:
12390051
19.

Treatment of restless legs syndrome.

Ferini-Strambi L, Manconi M.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S65-70. doi: 10.1016/S1353-8020(09)70838-7. Review.

PMID:
20123560
20.

Pramipexole for the treatment of restless legs syndrome.

Kushida CA.

Expert Opin Pharmacother. 2006 Mar;7(4):441-51. Review.

PMID:
16503816

Supplemental Content

Support Center